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Abstract
Background: Aging results in a progressive loss of skeletal muscle, a condition known as sarcopenia. Mitochondrial DNA
(mtDNA) mutations accumulate with aging in skeletal muscle and correlate with muscle loss, although no causal
relationship has been established.
Methodology/Principal Findings: We investigated the relationship between mtDNA mutations and sarcopenia at the gene
expression and biochemical levels using a mouse model that expresses a proofreading-deficient version (D257A) of the
mitochondrial DNA Polymerase c, resulting in increased spontaneous mtDNA mutation rates. Gene expression profiling of
D257A mice followed by Parametric Analysis of Gene Set Enrichment (PAGE) indicates that the D257A mutation is
associated with a profound downregulation of gene sets associated with mitochondrial function. At the biochemical level,
sarcopenia in D257A mice is associated with a marked reduction (35–50%) in the content of electron transport chain (ETC)
complexes I, III and IV, all of which are partly encoded by mtDNA. D257A mice display impaired mitochondrial bioenergetics
associated with compromised state-3 respiration, lower ATP content and a resulting decrease in mitochondrial membrane
potential (Dym). Surprisingly, mitochondrial dysfunction was not accompanied by an increase in mitochondrial reactive
oxygen species (ROS) production or oxidative damage.
Conclusions/Significance: These findings demonstrate that mutations in mtDNA can be causal in sarcopenia by affecting
the assembly of functional ETC complexes, the lack of which provokes a decrease in oxidative phosphorylation, without an
increase in oxidative stress, and ultimately, skeletal muscle apoptosis and sarcopenia.
Citation: Hiona A, Sanz A, Kujoth GC, Pamplona R, Seo AY, et al. (2010) Mitochondrial DNA Mutations Induce Mitochondrial Dysfunction, Apoptosis and
Sarcopenia in Skeletal Muscle of Mitochondrial DNA Mutator Mice. PLoS ONE 5(7): e11468. doi:10.1371/journal.pone.0011468
Editor: Mark A. Tarnopolsky, McMaster University, Canada
Received February 15, 2010; Accepted May 18, 2010; Published July 7, 2010
Copyright:  2010 Hiona et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by grants from the National Institute on Aging (AG17994 and AG21042) to CL, National Institutes of Health (AG021905) to
TAP, an American Heart Predoctoral Fellowship to AH (0415166B), an American Heart Postdoctoral Fellowship to TH (0525346B), a grant from the Academy of
Finland to AS, and an American Heart Predoctoral Fellowship to AYS (0615256B). Oxidative stress analysis was supported by the University of Florida Institute on
Aging and Claude D. Pepper Older Americans Independence Center (1 P30 AG028740) Genomics and Biomarker Core. This research was also supported in part by
I+D grants from the Spanish Ministry of Education and Science (BFU2006-14495/BFI), the Spanish Ministry of Health (ISCIII, Red de Envejecimiento y Fragilidad,
RD06/0013/0012, and PI081843), and the Autonomous Government of Catalonia (2005SGR00101) to RP and MPO. Additional support was provided to MT by the
National Projects on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science, and Technologies of Japan. Dr. Barger of
LifeGen Technologies was involved with analysis of gene expression data from microarray experiments. No other funders had a role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: GCK and TAP were awarded United States patent 7,126,040 for the PolgD257A mouse model. TAP is a co-founder and scientific
consultant for LifeGen Technologies, specializing in the application of DNA microarray analysis to analyzing nutraceutical interventions in aging. Dr. Barger of
LifeGen Technologies was involved with analysis of gene expression data from microarray experiments. This does not alter the authors’ adherence to all of the
PLoS ONE policies on sharing data and materials.
* E-mail: taprolla@wisc.edu (TAP); cleeuwen@aging.ufl.edu (CL)
¤ Current address: National Hellenic Research Foundation, Institute of Biological Research and Biotechnology, Athens, Greece
PLoS ONE | www.plosone.org 1 July 2010 | Volume 5 | Issue 7 | e11468
Introduction
The progressive loss of skeletal muscle mass and strength
observed in older individuals is a condition known as sarcopenia.
The associated muscle atrophy and weakness directly affect the
functional capacity and quality of life of the elderly. Sarcopenia
affects a growing population, occurring in 10–25% of individuals
under the age of 70 and in more than 40% of the elderly over the
age of 80 [1,2]. The annual cost of treating sarcopenia is greater
than the amount spent due to osteoporosis, yet little effort is made
to increase public awareness to prevent sarcopenia [3].
Despite the fact that in animal cells mtDNA comprises only 1–
3% of genetic material, several lines of evidence suggest that its
contribution to cellular physiology could be much greater than
would be expected from its size alone [4,5]. For instance, it
mutates at higher rates than nuclear DNA [6,7], which is probably
a consequence of: (a) its close proximity to the ETC, and thus of
greater exposure to reactants, (b) its lack of protective histones and
introns, and (c) its lack of extensive DNA repair systems compared
to the nuclear DNA [8,9,10]. Importantly, defects in the ETC can
have pleiotropic effects because they affect cellular energetics as a
whole [4]. For these reasons, a central role for mitochondrial DNA
(mtDNA) mutations in aging has been postulated [11,12,13].
Indeed, mtDNA mutations have been shown to accumulate with
aging in several tissues, including skeletal muscle of various species
[14,15,16,17,18,19].
Previous studies have provided strong, though correlative,
experimental support for an association between mtDNA
mutations and tissue dysfunction, particularly in long-lived post-
mitotic cells such as cardiomyocytes, skeletal muscle fibers and
neurons [14,16,17,18,19]. In order to determine whether mtDNA
mutations underlie sarcopenia, we used a genetically engineered
mouse model that expresses a proofreading-deficient version of the
mitochondrial DNA polymerase gamma (D257A), resulting in
increased spontaneous mutation rates in mtDNA [20,21]. We
have previously characterized accelerated aging in D257A mice
[20] and found that these mice exhibited multiple age-related
phenotypes including thymic involution, loss of bone mass, cardiac
dysfunction and hearing loss. These findings provide support for
the hypothesis that mtDNA mutations can play a causal role in
mammalian aging [20,21]. Therefore, the D257A mouse may
provide an in vivo model to study the mechanisms of skeletal muscle
loss with age, specifically, the contribution of mtDNA mutations.
The purpose of the present study was to identify the specific
molecular mechanism that links mtDNA mutations and the loss of
skeletal muscle mass with age in mitochondrial mutator mice [20].
The central hypothesis tested was that mutations in mitochondrial
DNA, known to be associated with aging in many post-mitotic
tissues, play a causal role in skeletal muscle loss of mutator mice by
affecting the assembly of fully functional ETC complexes, leading
to mitochondrial dysfunction and ultimately, to the activation of a
mitochondrial-mediated apoptotic program.
Results
D257A mice display significant skeletal muscle loss
At 11-mo of age, D257A mice exhibited significant skeletal
muscle loss of gastrocnemius (wild-type, WT: 0.15760.006 vs.
D257A: 0.12660.006 grams, p= 0.0004, 220%) and of quadri-
ceps muscle (WT: 0.19060.006 vs. D257A: 0.15660.007 grams,
p = 0.0003, 218% ) compared to WT mice (Fig. 1). The level of
sarcopenia is similar to that observed in gastrocnemius of
normally-aged (30-mo WT) mice compared to young mice (5-mo
WT) (gastrocnemius, 5-mo: 0.14660.009 vs. 30-mo: 0.11060.007
grams, p= 0.0095, 224.5%), but less than the level of sarcopenia
observed in quadriceps of aged WT mice (5-mo: 0.17760.004 vs.
30-mo: 0.10560.007 grams, p = 0.0095, 240%). We next
examined whether the observed sarcopenia was due primarily to
a reduction in muscle fiber size or fiber number and whether type
I or type II fibers were differentially affected. Muscle fiber number
and diameter were determined as described [22] for gastrocnemius
muscles isolated from 3-mo and 13-mo WT and D257A mice.
There were no significant differences between genotypes in the
number of type I or type II fibers at either age, although there was
a trend toward a lower proportion of type I fibers in the
gastrocnemius of D257A mice at both ages (Table 1). By contrast,
we observed a significant decrease in the diameter of type I (but
not type II) fibers at 13 months of age.
Gene expression profiling of D257A mice
Affymetrix Mouse Genome 430 2.0 arrays were used to
measure gene expression profiles in gastrocnemius muscle of 13-
month old WT and D257A mice. We then performed Parametric
Analysis of Gene Set Enrichment (PAGE) [23] to identify classes of
genes that were differentially expressed as a result of mtDNA
mutations induced by the error-prone mtDNA Polymerase c.
Comparison of 13-month old D257A mice with 13-month old WT
mice revealed numerous gene set categories significantly changed
in expression (Fig. 2A–C). D257A mice were associated with a
dramatic downregulation of ‘‘Biological Process’’ gene sets
associated with mitochondrial function, including electron transport
chain (GO:0022900), aerobic respiration (GO:0009060), and generation
of precursor metabolites and energy (GO:0006091) (Fig. 2A). Downreg-
ulation of ‘‘Molecular Function’’ gene sets was also associated with
decreased mitochondrial function, including oxidoreductase activity
(GO:0016491), NADH dehydrogenase activity (GO:0050662) and
cytochrome c oxidase activity (GO:0004129) (Fig. 2B). In the broader
‘‘Cellular Component’’ gene set category, the gene sets mitochon-
drion (GO:0005739), mitochondrial membrane (GO:0031966) and
mitochondrial inner membrane (GO:0005739) were downregulated
(Fig. 2C). These observations suggest that there is a transcriptional
program to reduce the expression of nuclear-encoded, mitochon-
drial transcripts in cells that carry functionally impaired mito-
chondria that result from the accumulation of mtDNA mutations.
Interestingly, gene sets associated with ribosomes or RNA
synthesis were the only category of gene sets upregulated in
D257A mice. Possibly, impaired bioenergetics in these animals is
associated with alterations in protein synthesis and a resulting
Figure 1. D257A mice display significant skeletal muscle loss.
At 11 mo of age, gastrocnemius (n = 22 per group, *p,0.001) and
quadriceps (n = 22 per group, *p,0.001) mean muscle mass in D257A
mice is significantly decreased compared to age-matched WT. Error bars
represent SEM.
doi:10.1371/journal.pone.0011468.g001
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attempt to increase protein synthesis through overexpression of
ribosomal/translation-related genes. Remarkably, no gene sets
associated with apoptosis or DNA damage were induced,
suggesting that apoptosis in D257A mice may be an intrinsic
mitochondrial process that occurs in the absence of transcriptional
induction of classical modulators of mitochondrial apoptosis in
response to DNA damage, such as Bak and Bax [24]. This
observation is in stark contrast with our previous DNA microarray
analysis of skeletal muscle of aged WT animals, which is associated
with a marked induction of genes associated with a p53-mediated
apoptotic response [25].
At the individual gene expression level, 97 genes were
significantly changed in expression in the 13-month old WT vs
D257A comparison (p,0.05, FDR ,0.05). Mitochondrial Crea-
tine Kinase 2 (Ckmt2) was the most significantly altered
mitochondrial function transcript (fold change = 1.7, p=1027,
FDR =0.004) (Table S1). Interestingly, comparison between 3-
month old WT and 3-month old D257A mice under the same
statistical parameters (including same FDR stringency) revealed no
significant changes in gene expression either at the individual
gene, or PAGE analysis. Thus, changes in gene expression due to
the D257A mutation in skeletal muscle develop later in life in
D257A mice, possibly as a consequence of progressive mtDNA
mutation accumulation and associated mitochondrial dysfunction.
D257A mice display decreased content and gene
expression of ETC Complexes I, III, and IV
We measured the content of ETC complexes I, II, III, IV and
the F1 domain of ATPase in 11-mo old WT and D257A skeletal
muscle using blue native PAGE (Fig. 3). We found that the total
content of complexes I (WT: 4005062281 vs. D257A:
2610062724 arbitrary units, p = 0.002, 235%), III (WT:
5097063673 vs. D257A: 3196064925 arbitrary units,
p = 0.0093, 237%), and IV (WT: 5090064782 vs. D257A:
2546065532 arbitrary units, p = 0.0046, 250%), all of which
contain subunits encoded by mtDNA, were profoundly reduced in
D257A mice (Fig. 3A, 3B). In contrast, the content of complex II
(WT: 2071064079 vs. D257A: 2861067051 arbitrary units,
p = 0.3513) and ATPase F1 (WT: 1976062831 vs. D257A:
183306747.9 arbitrary units, p = 0.64), both of which contain
only nuclear-encoded subunits, was not different between
genotypes (Fig. 3A, 3B). This observation reinforces the idea that
the accumulation of mtDNA point mutations directly affects the
assembly of complexes that are partly mitochondrial-encoded
[26], while strictly nuclear-encoded mitochondrial complexes
appear unaffected.
We also measured relative mRNA levels of nuclear encoded
genes of the ETC complexes I, III, and IV in 13-mo old WT and
D257A skeletal muscle by quantitative RT-PCR (Fig. 4). We
found that the mean relative mRNA expression of Ndufs1 (complex
I), Ndufv1 (complex I), Uqcrc1 (complex III), Cox6a2 (complex IV), and
Cox7a1 (complex IV) in the skeletal muscle of D257A mice was
significantly lower than that of WT mice (Fig. 4). These
measurements are in agreement with the general finding of
reduced expression of gene sets encoding mitochondrial proteins.
ETC complexes specific activities are unaffected in D257A
mice
The absolute activities of complexes I and IV (partly mtDNA-
encoded) appeared to be greatly reduced in the mutant mice
(Fig. 5A) whereas for the all-nuclear-encoded complex II, and
ATPase F1 domain, we observed no apparent differences between
genotypes (Fig. 5A). When we normalized the activity for each
sample to the respective respiratory complex content (specific
activity), however, we observed no significant differences between
WT and D257A mice for all complexes evaluated (Fig. 5B):
Complex I (WT: 314.50613.56 arbitrary units vs. D257A:
349.10628.80, p = 0.29), complex II (WT: 3136118.90 vs.
D257A: 163.80626.30, p = 0.26), complex IV (WT:
364.70619.60 vs. D257A: 4406100.50, p = 0.49), F1 domain of
ATPase (WT: 435.10696.50 vs. D257A: 384.30618, p = 0.62).
We note that large variability in the specific activity in some
animal groups (see WT group analysis of complex II activity) may
have affected our ability to detect significant changes.
D257A mice show decreased content of both nuclear-
encoded and mitochondrial-encoded ETC subunits and
total mitochondrial protein
In addition to measuring the content of fully assembled and
enzymatically active ETC complexes, we further determined the
content of selected individual subunits from each complex by
Western blotting experiments. We evaluated the subunits
NDUFA9 and NDUFS3 from complex I, both of which are
nuclear-encoded (Fig. 6A). We also evaluated two nuclear-encoded
subunits from complex III, 29 kDa and 48 kDa (Fig. 6A). Lastly,
we evaluated the mitochondrial-encoded COX1 subunit from
complex IV, which is a part of the active redox center of this
complex, and is essential for catalysis (Fig. 6A). We observed a
significant down-regulation of protein expression in the D257A
mice compared to WT for all subunits evaluated, whether nuclear-
or mitochondrial-encoded (NDUFA9-WT: 1.4760.14 arbitrary
units vs. D257A: 0.3660.02, p,0.0001), (NDUFS3-WT:
3.8060.20 vs. D257A: 3.1060.20, p = 0.03) (Complex III
48 kDa-WT: 2.0560.13 vs. D257A: 1.2060.07, p,0.0001)
(COX1-WT: 1.4460.12 vs. D257A: 0.5360.05, p,0.0001), with
the exception of the 29 kDa subunit of complex III, which only
tended to decrease (WT: 0.6060.06 vs. D257A: 0.4760.04,
p = 0.07) (Fig. 6B).
Table 1. Fiber type analysis in the gastrocnemius muscle of wild-type and D257A mice.
Age Genotype
Type I
Fiber diameter
(mm, mean ± SEM)
Type I
Fiber number
(mean ± SEM)
Type I Proportion
(%, mean ± SEM)
Type II
Fiber diameter
(mm, mean ± SEM)
Type II
Fiber number
(mean ± SEM)
Type II
Proportion
(%, mean ± SEM)
3 mo WT 22.98560.258 1793685 27.25761.330 31.32060.303 48326351 72.74361.330
3 mo D257A 22.81660.610 15116128 22.65961.427 33.07260.980 51446233 77.34161.427
13 mo WT 25.49461.368 15336127 26.58461.051 31.93861.373 42036188 73.41661.051
13 mo D257A 20.53560.516* 1612662 24.79261.265 28.93061.525 49296271 75.20861.265
*p,0.01, 13-month WT vs D257A type I fiber diameter comparison. All other comparisons, p.0.05.
doi:10.1371/journal.pone.0011468.t001
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Figure 2. Parametric Analysis of Gene Set Enrichment identifies Gene Ontology (GO) terms changed in gastrocnemius muscle of 13-
month old D257A mice as compared to 13-month old WT mice. (A, B, C) Terms shown are those significantly changed (p,0.01, FDR,0.01).
Red indicates a GO term that was induced by mtDNA mutations (Z-score.0); blue indicates GO terms that were suppressed by mtDNA mutations (Z-
score,0). n = 5 mice per group. (D) Genes listed within the GO term ‘‘electron transport chain’’ (Z-score =28.89; p,0.0001) whose expression level
significantly (p,0.01) increased (yellow) or decreased (blue) in D257A mice.
doi:10.1371/journal.pone.0011468.g002
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In addition, we compared the mitochondrial protein yield in
skeletal muscle of 11-mo and 13-mo old WT mice and D257A
mice using a standard Bradford assay. At 11 months of age, we
observed a significant reduction (235%) in mitochondrial protein
yield of D257A muscle (WT: 460.14 vs. D257A: 2.6060.06 mg of
mitochondrial protein/gram of muscle tissue, p= 0.0044). Addi-
tionally, we found that as the mutant mice approach their mean
lifespan of ,14-mo, mitochondrial protein yield is even more
drastically reduced; by 13-mo of age we detected a 45% decrease
compared to WT (WT: 4.3060.14 vs. D257A: 2.3560.20 mg of
mitochondrial protein/gram of muscle tissue, p,0.0001), suggest-
ing that mitochondria are progressively eliminated in skeletal
muscle of D257A mice.
Mitochondrial bioenergetics is impaired in D257A mice
At 11 months, O2 consumption during state 4, the resting state
of the mitochondria, did not differ between genotypes (WT:
12.7061.30 vs. D257A:11.9060.95 nmol O2/min/mg protein,
p = 0.31) (Fig. 7A). This was not unexpected because O2
consumption during this state is usually minimal. During the
Figure 3. D257A mice display decreased content of ETC Complexes I, III and IV compared to WT. (A) The total content of ETC complexes
I, II, III, IV and the F1 domain of the ATPase from skeletal muscle of 11-mo old WT and D257A mice (n = 7 per group) was determined using Blue Native
PAGE electrophoresis followed by staining with commassie blue stain. Proteins were separated according to molecular weight. Representative blots
are depicted. (B) Statistical analysis of ETC complexes content. Arbitrary units represent densitometry values normalized to total protein loaded
measured by the Bradford assay. Mean values 6SEM are shown. *p,0.01.
doi:10.1371/journal.pone.0011468.g003
Figure 4. D257A mice display decreased mRNA expression of
nuclear genes encoding components of ETC Complexes I, III
and IV. Relative mRNA expression of genes encoding components of
the ETC complexes I, III and IV, including Ndufs1, Ndufv1, Uqcrc1,
Cox6a2, and Cox7a1 was measured in the skeletal muscle from WT and
D257A mice at 13 months of age by quantative RT-PCR (n = 5 per
group). Mean values 6SEM are shown. *p,0.05.
doi:10.1371/journal.pone.0011468.g004
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phosphorylative state of the mitochondria, state 3 respiration,
mutant mitochondria displayed a marked decrease (243%) in
oxygen consumption (WT: 68.4065.10 vs. D257A: 396
5.80 nmol O2/min/mg protein, p = 0.0006) (Fig. 7A), which also
led to a significantly lower respiratory control ratio (RCR:
243%) (Fig. 7A) (WT: 5.7060.49 vs. D257A: 3.2760.39,
p = 0.0005). The RCR is used as an index of mitochondrial
coupling and metabolic activity. In the case of D257A
mitochondria, the significant decrease in RCR with unaltered
state 4 respiration denotes a low metabolic activity due to the
defects within the ETC complexes (the reduced content) that lead
to overall lower oxidative capacity.
D257A mice display decreased ATP content
ATP content was significantly lower in D257A mice compared
to WT (WT: 0.2960.08 vs. D257A: 0.1160.04 nmol ATP /mg
protein, p = 0.046) (Fig. 7B). It is apparent that the loss of ETC
complexes (Fig. 3A, 3B) can have an impact on ATP content.
Therefore, if ETC content is reduced in D257A muscle relative to
the amount of total mitochondrial protein, as we have observed, it
is logical to expect that the ATP content per amount of total
mitochondrial protein would be reduced due to fewer ETC
complexes per mitochondrion. Fewer ETCs cause a decrease in
state-3 capacity (Fig. 7A), which may provoke a decrease in
phosphorylation.
Mitochondrial membrane potential is significantly lower
in D257A mice
We determined the effect of increased mtDNA mutational load
on Dym of 13-mo old WT and D257A skeletal muscle
mitochondria. Dym was significantly lower in D257A mice during
both state 4 (WT: 195.2061.40 mV vs. D257A: 187.906
2.15 mV, p= 0.017) (Fig. 7C) and state 3 respiration (WT:
177.7062.50 vs. D257A: 167.3062.25 mV, p= 0.01) (Fig. 7C).
This drop in Dym is a consequence of the decreased proton
transport that results from the reduction in functional ETC
complexes and could be the trigger for the apoptosis we detected
in the mutant mice (see below for discussion of apoptosis).
Skeletal muscle mitochondria from D257A mice produce
significantly fewer ROS
We measured H2O2 produced by skeletal muscle mitochondria
of WT and D257A mice. H2O2 production was measured during
state 4 respiration because ROS production is higher when
electron flow is low (ROS production is nearly negligible during
state 3 respiration). At 11-mo of age, H2O2 production was
significantly decreased (233%) in D257A mice (WT: 0.6060.07
vs. D257A: 0.4060.05 nmol H2O2/min/mg protein, p= 0.01)
(Fig. 8A). The decreased H2O2 production by mutant mitochon-
dria also led to the calculation of a significantly lower free radical
leak percent (FRL%) (WT: 2.6060.30% vs. D257A: 1.8060.30%,
Figure 5. No differences between WT and D257A mice in ETC complexes I, II, IV and F1-ATPase specific activity. (A) The activity of ETC
complexes I, II, IV and the F1 domain of the ATPase, in skeletal muscle of 11-mo old WT and D257A mice (n = 7 per group), was determined using Blue
Native PAGE, followed by enzymatic colorimetric reactions performed on the gels. Representative blots are depicted. (B) Statistical analysis of ETC
complexes specific activity. Arbitrary units represent activity densitometry values normalized to respective content densitometry values for each
sample. No statistically significant differences were observed. Mean values 6SEM are shown.
doi:10.1371/journal.pone.0011468.g005
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p= 0.04) (Fig. 8A), suggesting that in these mitochondria, the
fraction of electrons which reduce O2 to ROS at upstream
components of the ETC instead of reaching cytochrome c oxidase
(COX) to reduce O2 to water, is much lower compared to WT.
D257A mitochondria produce fewer ROS in both main
ROS generators of the ETC: Complex I and Complex III
We evaluated site-specific ROS generation in 11-mo old mice
and found that muscle mitochondria from D257A mice produce
fewer ROS at complex III under basal conditions than do WT
mitochondria. This is true whether reverse electron flux through
complex I is permitted (WT: 6.3060.47 vs. D257A:
3.1360.48 nmol H2O2/min/mg protein, p = 0.0002) (Fig. 8 Bii)
or blocked via the complex I inhibitor rotenone (WT: 1.5060.14
vs. D257A: 0.9060.12, p = 0.005) (Fig. 8 Biii). Under maximal
conditions, D257A mitochondria have also reduced capacity to
generate ROS at both complex I (WT: 2.9060.23 vs. D257A:
1.2060.19, p,0.0001) (Fig. 8 Bi) and complex III (WT:
11.9061.20 vs. D257A: 6.7560.88, p = 0.003) (Fig. 8 Biv)
compared to WT. Moreover, the fact that H2O2 production is
decreased by nearly a factor of 4 for both WT and D257A mice
when the reverse electron flux is blocked (comparing Y axis values
from Fig. 8 Bii and Biii) signifies that this reverse flow is a
significant source of ROS produced by the ETC.
Mitochondrial DNA mutations cause mitochondrial
dysfunction in the absence of increased oxidative stress
In order to correlate our H2O2 results with further oxidative
stress, we next examined a marker of ROS-induced oxidative
damage to DNA, by assessing the levels of 8-oxo-7,8-dihydro-29-
deoxyguanosine (8-oxodGuo) in skeletal muscle mtDNA of 11-mo
old WT and D257A mice, using HPLC with electrochemical
detection. We did not find any differences in the levels of mtDNA
oxidation between WT and D257A mice (WT: 51.4066.30 vs.
Figure 6. D257A mice show decreased protein expression of both nuclear-encoded and mitochondrial-encoded ETC subunits. (A)
The content of selected nuclear-encoded (NDUFA9 and NDUFS3 subunits of Cx I, 29 kDa and 48 kDa subunits of Cx III), and mitochondrial-encoded
subunits (COX I subunit of Cx IV) in skeletal muscle extracts of 11-mo old WT and D257A mice (n = 11 per group) were evaluated by Western Blotting.
Representative blots are depicted. (B) Statistical analysis of ETC subunits protein expression. Arbitrary units represent densitometry values normalized
to porin. Mean values 6SEM are shown. *p,0.05. Cx: complex.
doi:10.1371/journal.pone.0011468.g006
mtDNA Mutations & Muscle Loss
PLoS ONE | www.plosone.org 7 July 2010 | Volume 5 | Issue 7 | e11468
D257A: 50.3067.20 8-oxodGuo/106 dGuo, p = 0.9) (Fig. 9A).
This is consistent with our previous results, which also showed no
significant differences between WT and D257A skeletal muscle in
F2-isoprostanes, a marker of lipid peroxidation [20]. Hence,
despite increased mutational load, mitochondria from D257A
mice do not show increased oxidative stress.
Figure 7. Mitochondrial bioenergetics is compromised in D257A skeletal muscle leading to a drop in mitochondrial Dym. (A) We
determined the effects of mtDNA mutations on O2 consumption of skeletal muscle mitochondria obtained from 11-mo old WT and D257A mice
(n = 11 per group). Oxygen consumption was measured during state 4 (non-phosphorylative state) with pyruvate/malate as substrate, and during
state 3 (phosphorylative state) with the addition of ADP. The respiratory control ratio (RCR), an index of mitochondrial coupling and metabolic
activity, was calculated by dividing state 3 by state 4 respiration values. Mean values 6SEM are shown. *p,0.001. (B) We evaluated ATP content in
skeletal muscle mitochondria of 11-mo old WT (n = 11) and D257A (n = 8) mice using a luciferin-luciferase based bioluminescence assay. Mean values
6SEM are shown. *p,0.05. (C) Changes in Dym were followed qualitatively by monitoring the fluorescence of TMRM that accumulates in energized
mitochondria of 13-mo old WT and D257A mice (n = 6 per group). Dym was measured during both state 4 (non-phosphorylative state) with
glutamate/malate as substrate and during state 3 (phosphorylative state) with the addition of ADP. Measurement of Dym after addition of CCCP
served as a control for TMRM loading in mitochondria. Mean values 6SEM are shown. *p,0.02.
doi:10.1371/journal.pone.0011468.g007
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No difference in antioxidant enzyme mRNA expression
between genotypes
We measured mRNA expression of Catalase and the
mitochondrial-specific isoform of superoxide dismutase (SOD),
MnSOD, via RT-PCR. We found no difference in either
Catalase (WT: 1.2060.08 vs. D257A: 1.1060.04 arbitrary units,
p = 0.1) (Fig. 9B) or MnSOD (WT: 0.8060.01 vs. D257A:
0.7060.07 arbitrary units, p = 0.3) (Fig. 9B) between
genotypes.
Apoptosis in D257A skeletal muscle is evident by an
increase in cytosolic mono- and oligo-nucleosomes
content
We quantified apoptotic DNA fragmentation by measuring the
amount of mono- and oligo-nucleosomes released into the cytosol,
using a quantitative ‘‘Cell Death’’ detection ELISA (Roche,
Germany). This assay detects the nucleosomal DNA digestion
products of ,180–200 bp or multiples thereof that are generated
during apoptosis. We observed a significant release of these
Figure 8. D257A mitochondria produce fewer ROS in both main ROS generators (Complex I and Complex III). (A) We measured H2O2
production using a sensitive fluorometric assay. Skeletal muscle mitochondria were obtained from 11-mo old, WT and D257A mice (n = 11 per group)
and supplemented with pyruvate/malate as substrate for oxidative phosphorylation. Pyruvate/malate was used to study complex I ROS production
(under near physiological conditions) which also represents total basal mitochondrial ROS production. Free radical leak percent (FRL%), an index of
mitochondrial efficiency, was calculated by dividing the H2O2 value by twice the state 4 respiration value and the result was multiplied by 100 to give
a % final value. Mean values 6SEM are shown. *p,0.05 (B) We used inhibitors of the ETC in order to study maximum rates of H2O2 production from
complexes I and III, since they represent the main sites of ROS generation within the mitochondria (n = 11 per group). For complex I maximum rate
(panel Bi) we used rotenone added to pyruvate/malate-supplemented mitochondria. For complex III maximum rate (panel Biv) we used antimycin A
plus rotenone, added to succinate- supplemented mitochondria. We also used mitochondria supplemented with succinate alone in order to study
complex III ROS production under near physiological conditions (panel Bii). In addition, some of the assays with succinate as substrate were
performed in the presence of rotenone (panel Biii), in order to avoid the backwards flow of electrons to Complex I. Mean values 6SEM are shown.
*p#0.005.
doi:10.1371/journal.pone.0011468.g008
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fragments into the cytosol of D257A muscle (WT: 0.11060.006 vs.
D257A: 0.17060.030 OD/mg protein, p= 0.035) (Fig. 10A).
DNA laddering is evident in skeletal muscle of D257A
mice
We corroborated the results of the cell death ELISA by
employing an alternate method for detecting apoptotic nucleoso-
mal DNA fragments, the DNA laddering assay. Prominent DNA
ladders are evident in muscle extracts from the D257A mice while
such ladders are not observed in WT mice (Fig. 10B).
Caspase-3 and caspase-9 activities are significantly
higher in D257A mice
We measured caspase-3 activity in the cytosol of 11-mo old WT
and D257A muscle and found that it is significantly higher in the
mutant mice (WT: 4362.70 vs. D257A: 57.7061.97 RFU/mg
protein, p = 0.0003) (Fig. 10C). Similarly, caspase-9 activity
showed a significant increase in D257A muscle compared to
WT muscle (WT: 35.4062 vs. D257A: 45.3061.70 RFU/mg
protein, p = 0.0014) (Fig. 10C). Activation of caspase-9 was
significantly correlated with increased caspase-3 activity for both
WT (r = 0.97, p,0.0001) and D257A mice (r = 0.80, p = 0.0029)
(Fig. 10D). These results reveal the induction of the mitochondrial-
mediated pathway of apoptosis because activation of the
mitochondrial pathway-specific caspase-9 leads to further cleavage
and activation of caspase-3, which is directly responsible for the
downstream events (i.e., cleavage of endo-nucleases and DNA
repair enzymes) that lead to apoptosis.
Discussion
The accumulation of multiple mtDNA point mutations and
deletions coincides with the age-dependent loss of muscle fibers in
multiple mammalian species [18,27,28,29,30]. Studies on sarco-
penia in rodents and humans, using laser capture microdissection
show that mtDNA deletions colocalize with ETC dysfunction in
specific fiber regions [14,31], with fibers manifesting the
phenotype when the ratio of deleted mtDNA genomes is above
80% [31]. Interestingly, mtDNA mutations are absent from
phenotypically normal regions within individual muscle fibers
Figure 9. Mitochondrial DNA oxidation levels and antioxidant enzyme mRNA expression remain unaltered in D257A skeletal
muscle. (A) We examined a marker of ROS-induced oxidative damage to DNA by assessing the levels of 8-oxodGuo in skeletal muscle mtDNA of 11-
mo old WT and D257A mice (n = 11 per group), using HPLC with electrochemical detection. No statistically significant differences were detected.
Mean values 6SEM are shown. (B) We measured Catalase and MnSOD mRNA expression in skeletal muscle extracts from 11-mo old WT (n = 7) and
D257A (n = 8) mice by RT-PCR. Arbitrary units represent specific mRNA densitometry values normalized to actin mRNA densitometry values. No
statistically significant differences were detected. Mean values 6SEM are shown.
doi:10.1371/journal.pone.0011468.g009
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[32]. Similarly, in aged (69–82 years old) human muscle, clonally
expanded base-substitution mutations and deletions in mtDNA are
associated with a deficiency in the mitochondrially encoded
cytochrome c oxidase (COX) [33]. Although ETC deficiency is
only observed in fiber regions that cointain high levels of mtDNA
deletions, it has been proposed that extension of the ETS-
abnormal region eventually extends throughout the length of the
fiber leading to fiber athrophy, breakage and loss [31]. Although
these studies do not prove causality, they provide evidence in
support of the hypothesis that mtDNA mutations and deletions
contribute to the development of sarcopenia. The question of
correlation versus causality has recently begun to be addressed by
the generation of mitochondrial mutator strains to investigate the
role of high mtDNA mutational load on sarcopenia [20]. Here, we
extend these observations to characterize in detail the sarcopenic
phenotype and mitochondrial respiratory function in skeletal
muscle from mutator mice.
Type I and type II muscle fiber numbers were not dramatically
different in D257A mice compared to WT control, at least in the
gastrocnemius muscle. We did find evidence of muscular atrophy
by 13 months in D257A gastrocnemius, represented by an ,20%
decrease in type I fiber diameter in these animals. A more
dramatic effect of mtDNA mutations accumulation on type I fibers
is consistent with the higher mitochondrial density, and reliance on
Figure 10. Apoptosis is evident in D257A muscle by increased cytosolic DNA fragments, DNA laddering, and caspase activation. (A)
Cytosolic fractions from 11-mo old WT and D257A skeletal muscle (n = 11 per group) were prepared. Nuclear DNA fragmentation was quantified as
the amount of mono- and oligo-nucleosomes present in the cytosol, using a sandwich ELISA. Mean values 6SEM are shown. *p,0.05. OD: optical
density. (B) DNA from 13-mo old WT and D257A (n = 8 per group) mice was extracted and subjected to a DNA laddering-specific ligation PCR. PCR
products were electrophoresed through 1% agarose gels and visualized under UV light for apoptosis-specific DNA ladders of,180–200 bp multiples.
Lane 1: 100 bp molecular marker. Lanes 2–9: WT PCR products. Lanes 10–17: D257A PCR products. Lane 18: Positive control. Lane 19: 500 bp
molecular marker. (C) Cytosolic fractions from 11-mo old WT and D257A skeletal muscle (n = 11 per group) were prepared. Caspase -3 and -9 activities
were measured using a fluorometric protease assay kit which is based on detection of cleavage of the substrates DEVD-AFC or LEHD-AFC by caspase-
3 and -9 respectively. Mean values 6SEM are shown. *p,0.002. RFU: raw fluorescent units. (D) Caspase-3 activity was correlated with caspase-9
activity in WT and D257A mice (n = 11 per group). Pearson correlation r values are shown in the top right corner. Correlations were significant for both
genotypes; WT: r = 0.97, p,0.0001 and D257A: r = 0.8, p,0.003.
doi:10.1371/journal.pone.0011468.g010
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oxidative phosphorylation in these so-called ‘‘slow twitch’’ fibers
relative to classic ‘‘fast twitch’’ type II (particularly type IIb) fibers.
Remarkably, the pattern of type I fiber diameter reduction in
D257A mice is different than that observed in rodents [34], and
humans [35], which are associated with type II fiber atrophy with
age. Possibly, the very high load of mtDNA mutations in D257A
mice as compared to normally aged WT mice, leads to preferential
dysfunction of type I fibers, which rely heavily on oxidative
phosphorylation. The difference in fiber type alterations in D257A
mice and normal aging could also be interpreted as evidence that
mtDNA mutations are not the initiating event in fiber atrophy and
sarcopenia in humans. Different mechanisms of muscle aging in
D257A and wild-type mice are also supported by the DNA
microarray analysis, which is characterized by an extensive
induction of p53-induced apoptotic genes in aged wild-type
muscle [25], but not in D257A mice as reported here. This may
reflect an increased contribution of nuclear genomic instability in
normal aging, as compared to aging of D257A mice. However, we
also note that the type of mtDNA lesions may play a role in the
different observations of D257A mice and normal aging.
Importantly, in D257A mice mtDNA point mutations appear to
be the predominant lesion [26], whereas mtDNA large deletions
are associated with regional fiber dysfunction in humans [31].
We found robust decreases in mitochondrial state 3 (phosphor-
ylative state) O2 consumption and significantly lower mitochondrial
ATP content in gastrocnemius and quadriceps muscles fromD257A
mice, compared to WT animals. D257A mitochondria were
profoundly less metabolically active than controls, as reflected by
respiratory control ratios (state 3/state 4 O2 consumption) of less
than 3.5. These findings clearly indicate that oxidative phosphor-
ylation is compromised in skeletal muscle of mutant mice and
provide a causal role for mtDNA mutations in skeletal muscle
mitochondrial dysfunction. It should be noted that decreases in ATP
synthesis and state 3 respiration during normal aging are all well-
documented for multiple species and tissues, including human
skeletal muscle [36,37,38,39,40,41]. Our findings in skeletal muscle
are also consistent with those of Trifunovic and colleagues, which
demonstrated a severe decline in mitochondrial respiration in
mouse embryonic fibroblasts and impaired ATP production in the
hearts of similar mutator mice [21,26,42].
These defects in oxidative phosphorylation are likely the cause
of the drop in mitochondrial membrane potential (Dym) that we
have detected in mitochondria from mutant mice. Low Dym has
also been observed in mitochondria isolated from normally-aged
(,20–30 mo) rodents and from fibroblasts of elderly ($60 yr)
human subjects [43,44,45,46,47], and was found to correlate with
reduced ATP synthesis. A reduction in Dym leads to matrix
condensation and release of pro-apoptotic factors into the cytosol,
facilitating cell death [48]. In our D257A model, the drop in Dym
was indeed accompanied by up-regulation of apoptosis, as
evidenced by an increased release of mono- and oligo-nucleosomal
fragments into the cytosol, prominent DNA laddering and up-
regulation in the activities of caspase-9 and caspase-3. The
observation of increased caspase-9 activity as well as the significant
positive correlation between caspase-3 and caspase-9 activity in
D257A mice suggests that activation of the mitochondrial pathway
is at least partly responsible for the apoptosis we detected in
D257A muscle. Accelerated skeletal muscle apoptosis has been
well documented with aging [49,50] and we previously showed
that increased caspase-3 cleavage is characteristic of skeletal
muscle during normal aging [20]. Furthermore, previous studies
have suggested that age-related apoptosis and/or necrosis in
response to energy depletion may occur through activation of the
mitochondria-mediated signaling pathway [48,51,52,53].
Accumulation of mtDNA mutations and deletions will likely
have a direct impact on the transcription and translation of ETC
complexes and may preclude the assembly of functional complexes
within the inner mitochondrial membrane. Decreases in the
activity of ETC complexes with age, and in association with
accumulated mtDNA mutations/deletions, are documented in
skeletal muscle of rodents and humans [14,54,55,56,57,58].
Interestingly, D257A mice showed a significant decrease in the
content of fully assembled, enzymatically active complexes I, III
and IV, all of which contain subunits encoded by mtDNA, while
the content of all nuclear-encoded complexes II and F1 domain of
ATPase showed no difference between genotypes. This confirms
our hypothesis that mtDNA mutations have a direct impact on the
assembly of functional ETC complexes that are comprised of
mtDNA-encoded subunits. Importantly, when ETC complex
specific activity was determined, we did not detect significant
differences between genotypes in any of the complex activities,
suggesting that either only functional complexes assemble or
dysfunctional complexes are effectively degraded. However, this
remains to be determined. Nonetheless, even if the activity of the
remaining ETC complexes in mutant mitochondria is normal, the
reduced amount of functional complexes still creates energy
deficits resulting in mitochondrial dysfunction. A point that
requires special attention regarding measurements of ETC
complex enzymatic activities is how the complex activities are
expressed. In most cases, enzymatic activities are normalized to
total protein content [37], or expressed as a ratio to nuclear-
encoded citrate synthase activity [57]. In such cases, the overall
activity per amount of mitochondrial protein may not reflect
decreases in the actual activity of the individual complexes, but
instead decreases in the abundance of the complex [37]. We
determined specific activity, as well as complex abundance in
order to gain a more precise understanding of the specific defects
occurring within D257A mitochondria. Thus, our results show
that ETC complexes do not assemble as often in D257A mutant
mitochondria. However, those complexes that do manage to
assemble have normal activity, perhaps because complexes
containing altered proteins might be short-lived.
We also observed a significant down-regulation of mitochon-
dria-related gene sets, and also ETC complex subunits expression
in the D257A muscle, whether nuclear- or mitochondrial-
encoded. The reduced expression of nuclear-encoded subunits
may be the consequence of a reactive adaptation of the nucleus. In
agreement with this hypothesis, Alemi et al. demonstrated that
pathogenic mtDNA deletions had a strong negative effect on
nuclear-encoded mitochondrially targeted genes [59]. They
proposed that the nucleus senses the irreversible depletion of
mtDNA-encoded subunits and responds by down-regulating the
interacting subunits that would normally form a functional
complex. This proposed down-regulation of nuclear-encoded
genes related to mitochondria is fully supported by our gene
expression findings, and is likely to exacerbate the mitochondrial
defect initiated by the mtDNA mutations.
Besides a reduction in the abundance of ETC complexes, we
further detected significantly lower mitochondrial protein yield in
the mutant mice. Age-related decreases in mitochondrial protein
yield in rodent skeletal muscle have been previously reported
[60,61], but this finding is not uniform [62]. By 11-mo of age, we
detected a 35% reduction and at ,13 months, an even more
dramatic 45% reduction in mitochondrial protein yield from
D257A muscle, suggesting that mitochondrial content is contin-
uously lost in these animals as they are approaching their mean
lifespan of ,14 months. Because we observed decreased ETC
complex content and reduced mitochondrial protein yield in
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D257A muscle with age, we speculate that this may reflect the
selective elimination of dysfunctional, mutation-bearing mitochon-
dria containing the fewest functional ETCs.
The hypothesis that aging is due in part to mtDNA damage and
associated mutations [12,13] was based on the observations that
mtDNA is located in the organelle that generates the most cellular
ROS and it is relatively unprotected from ROS damage compared
to nuclear DNA [6,7]. The main tenet of the free radical theory of
aging [63] is that aging is due to the progressive accrual of ROS-
inflicted damage, including mtDNA mutations, the accumulation
of which has been postulated to lead to a ‘‘vicious cycle’’ of further
mitochondrial ROS generation and mitochondrial dysfunction
[12,13]. The increased production of ROS as a consequence of
mtDNA mutations has been demonstrated in some circumstances
[64,65]. In contrast to these studies, however, we and others have
clearly demonstrated that mitochondrial mutator mice do not have
increased levels of oxidative stress [20,42,66]. In this study, we
further report that in D257A skeletal muscle, mitochondrial ROS
production is significantly decreased as compared to WT tissue.
Both the basal and maximal ROS production at complex I and at
the proton motive Q cycle operating in complex III – the two
major ROS sites within the ETC – were significantly lower in
mutant skeletal muscle. These results suggest that ROS production
is regulated in a tissue-specific way, at least in the D257A model,
and does not necessarily play a role in the increased sensitivity to
apoptosis. Importantly, we also found no up-regulation in either
MnSOD or Catalase mRNA levels, substantiating that ROS levels
are decreased in mutant mice due to a lower ROS production and
not due to an up-regulation in antioxidant defenses.
In agreement with the ROS data, we found that muscle mtDNA
oxidative damage, as measured by 8-oxodGuo, was not different
between genotypes. This agrees with our previous 8-oxodGuo data
in D257A liver [20] as well as with oxidative stress data reported
by others in liver and heart using D257A mutator mice or mice
with a heart-specific mitochondrial mutator defect [42,66]. Note
that we did not detect a significant change in 8-oxodGuo levels,
despite a drop in H2O2 production which may implicate non-ETC
and extramitochondrial sources of ROS in mtDNA damage [67].
Furthermore, the paired observations of decreased ROS produc-
tion and a lowered Dym in D257A mice are consistent with the
widely accepted notion that increased ROS generation occurs at
high mitochondrial Dyms [68,69].
We do not postulate that chronic ROS production and
oxidative stress do not contribute to mtDNA damage and
mutagenesis in the context of normal aging. In fact, expression
of a mitochondrially targeted catalase in wild-type mice suppresses
age-related mtDNA mutations and deletions [70,71]. Our results
from the D257A model, however, clearly support the idea that in
skeletal muscle, mtDNA mutagenesis does not lead to further
increases in ROS production and oxidative stress and therefore,
these are not important mediators of apoptosis in this animal
model. Hence, based on our collective results, we propose instead
that respiratory chain dysfunction per se is the primary inducer of
the sarcopenic phenotype.
We note the observations of Bandy and Davison, the first
investigators to put forward a mechanistic elaboration of the
mitochondrial ‘‘vicious cycle’’ theory. While they showed that some
mtDNA mutations may stimulate ROS production, they also
carefully noted that mutations preventing the synthesis of
cytochrome b would actually abolish any superoxide production
at complex III that normal mitochondria might exhibit, because
without cytochrome b in place, complex III cannot be assembled
[72]. Later studies also reported that cells possessing large mtDNA
deletions would indisputably preclude assembly of both the enzyme
complexes known to be responsible for mitochondrial ROS
production, complexes I and III [27,73,74,75]. Our findings of
lower complex I and III content in combination with lower complex
I and III ROS production are in agreement with those studies.
We note that there is debate on the contributing role of point
mutations as opposed to deletions in the manifestation of the
premature aging phenotypes in mitochondrial mutator mice.
Interestingly, heterozygous D257A animals are able to sustain a
500-fold higher mtDNA mutation burden than WT mice without
any obvious features of rapidly accelerated aging, indicating that
mtDNA point mutations do not limit the natural lifespan of WT
mice [70]. We have previously shown that mtDNA deletions
accumulate at an accelerated rate in tissues of homozygous D257A
(the mice used in this study), and postulated that they may
represent the main driving force behind the shortened lifespan and
the various aging phenotypes in these mice [71]. Moreover,
clonally expanded mutations were also evident in D257A mice as
demonstrated by cells with a COX negative phenotype in various
tissues investigated [71]. However, a recent study reports no major
reductions in the levels of mitochondrially encoded transcripts in
D257A mice, suggesting that large numbers of point mutations (as
opposed to deletions) underlie the phenotypes of D257A mice
[26]. In our view, it is likely that both mtDNA deletions and point
mutations contribute to the phenotypes observed in homozygous
D257A mice, but that these lesions may have different abundance
and consequences in different tissues.
The D257A mice are the first ‘‘in vivo’’ mammalian system that
allows detailed examination of the causal role of mtDNA
mutations in skeletal muscle aging. We observed no differences
between genotypes in muscle mass [20], caspase-3 cleavage [20],
gene expression patterns, mitochondrial bioenergetics (Fig. S1)
and ROS production (Fig. S2) at an early age (3-mo), suggesting
that the sarcopenic phenotype in D257A mice is age-induced and
not due to developmental defects, underscoring the utility of
D257A mice as a model of age-related mitochondrial dysfunction.
We propose that the reduction in functional complexes I, III and
IV formation in D257A mice represents the primary mechanism
responsible for impaired mitochondrial bioenergetics (limited
oxidation and phosphorylation capacities). Ultimately, lower
electron transfer and decreased proton pumping lead to
disturbances in Dym and mitochondrial-mediated apoptosis.
Importantly, this work is also the first to demonstrate specifically
in skeletal muscle, that mtDNA mutations lead to mitochondrial
dysfunction concurrent with decreases in ROS production, in
contrast to the mitochondrial ‘‘vicious cycle’’ theory of aging. This
reduction in ROS is possibly due to: (a) the drop in Dym, and (b)
the less frequent formation of the main ROS generators,
complexes I and III. Our findings suggest that accumulation of
mtDNA mutations and associated respiratory dysfunction may
lead to the activation of apoptosis and loss of irreplaceable cells in
susceptible tissues, and therefore may be an important contributor
to the aging process.
We note that the D257A model does not represent the multiple
aspects of normal skeletal muscle aging, but is a model that
addresses the role of mtDNA mutations in age-related mitochon-
drial dysfunction. Although mtDNA deletions were found to
accumulate significantly in tissues of WT mice with age, they
accumulate at a 7–11 fold higher level in tissues of D257A mice
[70], while point mutations can reach ,2,500-fold higher
occurrence compared to WT mice [71]. Moreover, because cells
may have hundreds of mitochondria, and each carries multiple
copies of mtDNA likely coexisting as heteroplasmic mtDNA
sequences, the contribution of mtDNA mutations and deletions to
normal aging phenotypes remains a controversial issue.
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Materials and Methods
Generation of D257A mice
The generation of PolgD257A transgenic mice has been previously
reported [20]. Briefly, the D257A mutation results in a critical
residue substitution in the conserved exonuclease domain of
POLG, impairing its proofreading ability. Germline transmission
of the mutation produced Polg+/D257A mice, which were
intercrossed to generate homozygous PolgD257A/D257A mice,
hereafter denoted D257A.
Animals
All animal research was conducted in accordance with the
regulatory policies of the Institutional Animal Care and Use
Committees of the University of Florida (CL approved protocol
#D420) and the University of Wisconsin-Madison (TAP approved
protocol #M01265). Male and female WT and D257A mice
(initially of a mixed 129Sv/ICR/B6 background before being
backcrossed for 4 generations into a C57Bl/6J background) were
sacrificed at 11 and 13 months of age, timepoints at which the
D257A mice exhibit age-related muscle loss; indeed, muscle loss
may be evident as early as ,9 months of age in these mice [20].
Males and females were pooled for statistical analysis based on our
previous observation that there are no differences between sexes in
the parameters studied in WT mice of the same background [76].
The animals were housed in quarantines in a climate- and light-
controlled facility. After one week of acclimation in the facility the
animals were sacrificed by rapid cervical dislocation. Four animals
a day were sacrificed. For all of our experiments we used and
compared two groups: WT versus D257A mice. For some
experiments, 3 mo-old WT and D257A mice were also used
(refer to Fig. S1 and S2). Five-mo (n= 15) and 30-mo old (n = 10)
WT animals of the same background strain were also used for
muscle weight comparisons.
Measurements of number and diameter of muscle fiber. Type I
and II fibers were discerned with NADH-tetrazolium reductase
stain. Detailed protocols for the stain have been described [22].
The number and diameter of each type fiber were measured in the
microscopic images of transverse sections of the gastrocnemius
muscles. The diameter was calculated by Image J (NIH) and the
data sets from .150 type I fibers and .200 type II fibers were
analyzed by ANOVA with Bonferroni’s multiple comparison test.
Mitochondrial and cytosolic isolation
Mitochondrial and cytosolic protein fractions were isolated
using differential centrifugation as previously described [76].
Immediately after sacrifice, skeletal muscles from 11-mo old WT
and D257A mice (both gastrocnemius and quadriceps muscles
were pooled together for all of our biochemical analyses) were
extracted, rinsed in saline solution, weighted, then finely minced
and homogenized in (1:5 wt/vol) ice-cold isolation buffer contain-
ing 0.21 M mannitol, 0.07 M sucrose, 0.005 M Hepes, 0.001 M
EDTA, 0.2% fatty acid-free BSA, pH 7.4, using a Potter-Elvehjem
glass homogenizer. The homogenate was centrifuged at 1,0006 g
for 10 min at 4uC. The supernatant was then centrifuged at 14,000
6 g for 20 min. After the second spin, the supernatant (crude
cytosol) was stored at 280uC and the mitochondrial pellet was
resuspended in isolation buffer without BSA and was centrifuged
again at 14,0006 g for 10 min. The final mitochondrial pellet was
resuspended in 350 ml of isolation buffer without BSA.
Total basal and site-specific ROS production
The rate of mitochondrial H2O2 production was assayed in
freshly isolated mitochondria by a highly sensitive fluorometric
method according to Barja [77], and adapted to a microplate
reader [76]. H2O2 generation was monitored by measuring the
increase in fluorescence (excitation at 312 nm, emission at
420 nm) due to the oxidation of homovanillic acid by H2O2 in
the presence of horseradish peroxidase. The assay was performed
in incubation buffer (145 mM KCl, 30 mM Hepes, 5 mM
KH2PO4, 3 mM MgCl2, 0.1 mM EGTA, 0.1% BSA, pH 7.4) at
37uC, and the reaction conditions were: 0.25 mg of mitochondrial
protein per mL, 6 U/mL of horseradish peroxidase, 0.1 mM
homovanillic acid and 50 U/mL of superoxide dismutase (SOD).
The reaction was initiated by the addition of 2.5 mM pyruvate/
2.5 mM malate as substrate for oxidative phosphorylation.
Pyruvate/malate was used to study complex I ROS production
which also represents total basal mitochondrial ROS generation.
5 mM succinate without addition of inhibitors was used to study
complex III ROS production, under near physiological conditions,
as previously described [76,77]. We also used inhibitors of the
ETC in order to study maximum rates of H2O2 production from
complexes I and III, since they represent the main sites of ROS
generation within the mitochondria. For the determination of
maximal H2O2 production by complex I, 2 mM rotenone was
added to 2.5 mM pyruvate/2.5 mM malate-supplemented mito-
chondria. For the determination of maximal H2O2 production by
complex III, 2 mM antimycin A plus 2 mM rotenone were added
to succinate-supplemented mitochondria. In addition, some of the
assays in which succinate was used as the substrate were performed
in the presence of 2 mM rotenone alone, in order to avoid the
‘‘backward’’ flow of electrons to Complex I. After 15 min of
incubation at 37uC, the reaction was stopped and the samples
were transferred on ice and a stop solution (0.1 M glycine, 25 mM
EDTA, pH 12) was added. Known amounts of H2O2 generated in
parallel by glucose oxidase, with glucose as substrate, were used as
standards. All samples were run in duplicate.
Mitochondrial respiration
Mitochondrial oxygen consumption was measured at 37uC by
polarography, with a Clark-type oxygen electrode (Oxytherm,
Hansatech, Norfolk, UK) under the same conditions used (same
mitochondrial preparation, buffer composition and substrate
concentrations) for H2O2 production measurements. The assay
was performed in the absence (State 4-resting state) and in the
presence (State 3-phosphorylating state) of 500 mM ADP.
ATP content
Mitochondria isolated from skeletal muscle were used immedi-
ately after isolation to determine mitochondrial ATP content with
a luciferin-luciferase based bioluminescence assay, following the
method of Drew [78]. ATP content methodology was modified
from a method of Molecular Probes (A-22066, Eugene, OR,
USA). The chemicals used were D-luciferin, luciferase (40 mL of a
5 mg/mL solution in 25 mM Tris-acetase, pH 7.8, 0.2 M
ammonium sulfate, 15% (v/v) glycerol and 30% (v/v) ethylene
glycol), dithiothreitol (DTT), adenosine 59-triphosphate (ATP),
and a Reaction Buffer (10 mL of 500 mM Tricine buffer, pH 7.8,
100 mM MgSO4, 2 mM EDTA and 2 mM sodium azide). The
reagents and reaction mixture were combined according to the
protocol by Molecular Probes. In order to determine ATP content,
freshly isolated mitochondria were added to a cuvette containing
reaction buffer, D-luciferin, luciferase and DTT. In addition,
2.5 mM pyruvate and 2.5 mM malate were added to the reaction
mixture, as substrates for oxidative phosphorylation. Known
concentrations of ATP standards were used to establish a standard
curve. The values for ATP content were normalized to total
mitochondrial protein concentration.
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Mitochondrial membrane potential
Dym changes in isolated skeletal muscle mitochondria were
followed qualitatively by monitoring the fluorescence of tetra-
methyl rhodamine methyl ester (TMRM, Molecular Probes,
Eugene, OR, USA), a cationic lipid-soluble probe that accumu-
lates in energized mitochondria. The method of Scaduto [79] was
followed without modification. Briefly, mitochondria (0.25 mg/ml)
were incubated at 37uC in a medium composed of 135 mM KCl,
20 mM MOPS, 5 mM K2HPO4, and 5 mM MgCl2 at pH 7.00.
The experiment was initiated by the addition of mitochondria to
the medium, also containing 0.33 mM TMRM and 5 mM
glutamate +2.5 mM malate in order to record Dym during state
4. Fluorescence at 546 and 573 nm excitation was monitored
using an emission wavelength of 590 nm. This was followed by the
addition of ADP (0.17 mM) to record Dym during state 3.
Addition of 0.5 mM CCCP served as a positive control, to assess
Dym in completely depolarized mitochondria.
Calculation of the mitochondrial free radical leak
H2O2 production and O2 consumption were measured in
parallel in the same muscle mitochondria under similar experi-
mental conditions. This allowed the calculation of the fraction of
electrons which reduce O2 to ROS at upstream components of the
respiratory chain (the percent free radical leak or FRL%) instead
of reaching cytochrome oxidase to reduce O2 to water. Because
two electrons are needed to reduce 1 mole of O2 to H2O2 whereas
four electrons are transferred in the reduction of 1 mole of O2 to
water, the percent free radical leak can be calculated as the rate of
H2O2 production divided by two times the rate of O2
consumption, and the result is multiplied by 100.
Calculation of the mitochondrial respiratory control ratio
(RCR)
Measurement of oxygen consumption using a Clark-type
electrode in the absence (State 4) and presence (State 3) of
saturating amounts of ADP (500 mM) allowed calculation of the
respiratory control ratio (RCR) (State 3/State 4 oxygen consump-
tion) as an indicator of the degree of coupling and metabolic
activity of the mitochondrial preparations.
Determination of mitochondrial protein yield
In order to determine mitochondrial yield, we first determined
the total protein concentration in each mitochondrial extract by
the Bradford assay. Each concentration value was multiplied by
the total volume of each mitochondrial suspension. This product
was divided by the skeletal muscle weight used each time to obtain
the respective mitochondrial extract. Mitochondrial yield was
expressed as total mitochondrial content per gram of skeletal
muscle tissue.
Microarray Analysis
Details regarding sample preparation and array hybridization
are described elsewhere [80] (see also Supporting File S1). Briefly,
total RNA was isolated from gastrocnemius muscle using
TRIZOL (Invitrogen, Carlsbad, CA, USA) and 5 individual
samples from each group were used for the DNA microarray
experiments. DNA chips were hybridized with synthesized biotin-
labeled cRNA and scanned with a GeneArray Scanner (Affyme-
trix, Santa Clara, CA, USA). We performed Parametric Analysis
of Gene Set Enrichment (PAGE) [23] to identify classes of genes
that were differentially expressed as a result of mtDNA mutations.
Genes were annotated with functional data from the Gene
Ontology (GO) consortium (http://www.geneontology.org). We
considered GO terms that were annotated at Level 3 or greater
and were represented by at least 10 but not more than 1000 genes.
A GO term was considered to be significantly changed by
treatment if the p-value for both the PAGE and a False Discovery
Rate (FDR) analysis was ,0.01. We also calculated Z ratios for
each gene set, which serve as a normalization factor [81].
Quantitative RT-PCR
Detailed protocols for quantitative RT-PCR analysis have been
described [82]. The gastrocnemius muscles were dissected, frozen
in liquid N2, and stored at280uC. Total RNA was extracted from
the frozen tissues using the TRIZOL reagent. Detection of mRNA
was carried out with the TaqMan EZ RT-PCR kit using an
Applied Biosystems 7500 Real-Time PCR System (Applied
Biosystems, Foster City, CA, USA). b-Actin was used as an
internal standard. Oligonucleotide primers and MGB fluorescent
probes (TaqMan Gene Expression Assays) were purchased from
Applied Biosystems. Samples were run in duplicate.
Oxidative Damage to mtDNA
Mitochondrial DNA oxidation was measured according to Sanz
et al. [83], with modification. Briefly, mitochondrial DNA, free of
nDNA, were isolated by the method of Latorre et al. [84], adapted
to mammals [85]. After isolation mtDNA was completely dissolved
in 85 mL water containing 30 mM deferoxamine mesylate (Sigma
Aldrich, St. Louis, MO, USA), DNA was digested with 4 U of
Nuclease P1 (dissolved in 300 mM sodium acetate, 0.2 mM
ZnCl2, pH 5.3), and 5 U of alkaline phosphatase during 60 min at
50uC. After filtering, samples were put into an autosampler vial at
4uC for HPLC-EC-UV analysis. 8-oxo-7,8-dihydro-29-deoxygua-
nosine (8-oxodGuo) and 29-deoxyguanosine (dGuo) were mea-
sured by HPLC with online electrochemical and ultraviolet
detection respectively. For analysis, the nucleoside mixture was
injected into two Delta-Pak (15063.9 mm id, 5 mm) C-18
reversed-phase columns (Waters, Milford, MA, USA). 8-oxodGuo
was detected with an electrochemical detector (Coulochem III,
ESA Inc, Chelmsford, MA, USA) with a PEEK filter protected
5011A analytical cell (ESA, 5 nA; screen electrode: +205 mV;
analytical electrode: +275), and dG was measured with a Spectra
SYSTEM UV1000 detector (Thermo Electron Corp., San Jose,
CA, USA) set at 290 nm. Chromatograms were recorded using
EZChrome Elite (Scientific Software INC., Pleasanton, CA, USA).
Calibration curves for dGuo and 8-oxodGuo were constructed by
injection of each standard 3–4 times. The HPLC buffer consisted
of 9% v/v methanol and 50 mM sodium acetate, set to pH 5.3,
with acetic acid, then filtered through a CN 0.2 mm filter from
Nalgene Nunc (Rochester, NY, USA).
Blue native polyacrylamide gel electrophoresis (BN-
PAGE) analysis for determination of content and
enzymatic activity of respiratory complexes
For determination of the content of the ETC complexes, we
followed the protocol as described by Schagger et al. with some
modification [86]. Skeletal muscle was homogenized in buffer 1
containing 20 mM MOPS, 440 mM sucrose, 1 mM EDTA and
0.5 mM PMSF, pH 7.2 at 4uC. The homogenates were
centrifuged at 20,000 x g for 20 min. The pellet was resuspended
in 80 ml of buffer containing 1 M aminocaproic acid, 50 mM Bis-
tris and 0.5 mM PMSF, pH 7.0. The membranes were then
solubilized by the addition of 30 ml n-dodecylmaltoside (10%,
prepared fresh), followed by ultracentrifugation for 25 min at
100,000 x g. The supernatant, containing all the solubilized
mitochondrial membrane proteins was used for the BN-PAGE.
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7 ml of 5% w/v coomassie brilliant blue G-250 in aminocaproic
acid (1 M) were added to 100 ml of supernatant and samples were
loaded to a gel. For electrophoresis, a 3–12% gradient gel with 4%
of stacker was used. The anode buffer was comprised of 50 mM
Bis-Tris, pH 7.0. The cathode buffer was comprised of 50 mM
tricine, 15 mM Bis tris, and coomassie brilliant blue G-250 (0.02%
w/v), pH 7.0. Samples were electrophoresed at 90 V for 20 min,
and thereafter at 170 V for 2 h, at 4uC. Immediately after
electrophoresis gels were incubated in coomassie brilliant blue G-
250 solution (0.1% coomassie in 10% acetic acid and 40%
methanol) for 1 h, followed by incubation in de-staining solution
(10% acetic acid, 40% methanol) for 2 h. After de-staining, gels
were photographed and analyzed using the Alpha Innotech
FluorChem SP imaging system (Alpha Innotech, Santa Clara, CA,
USA). Densitometry values were normalized to total protein
loaded per well, measured by the Bradford assay [87]. For
determination of enzymatic activity, enzymatic colorimetric
reactions were performed on the BN-PAGE. Gels were incubated
overnight at room temperature with the following solutions:
Complex I: 2 mM Tris–HCl, pH 7.4, 0.1 mg/ml NADH, and
2.5 mg/ml NTB (nitrotetrazolium blue). Complex II: 4.5 mM
EDTA, 10 mM KCN, 0.2 mM phenazine methasulfate, 84 mM
succinic acid and 50 mM NTB in 1.5 mM phosphate buffer,
pH 7.4. Complex IV: 5 mg 3:30-Diamidobenzidine tetrahy-
drochloride (DAB) dissolved in 9 ml phosphate buffer (0.05 M,
pH 7.4), 1 ml catalase (20 mg/ml), 10 mg cytochrome c, and
750 mg sucrose. Complex V: 35 mM Tris, 270 mM glycine,
14 mM MgSO4, 0.2% Pb(NO3)2, and 8 mM ATP, pH 7.8. Gels
were then washed in distilled water and photographed immedi-
ately. Densitometry values for activity were normalized to
respective content densitometry values.
Western blots of selected mitochondrial- and nuclear-
encoded subunits from ETC complexes I, III, and IV
The protein content of skeletal muscle mitochondrial respira-
tory chain complexes was estimated using Western blot analysis.
Immunodetection was performed using specific antibodies for the
39 kDa (NDUFA9) and 30 kDa (NDUFS3) subunit of complex I
(1:1000 and 1:1000, respectively), 48 kDa (CORE 2) and 29 kDa
(Rieske iron-sulfur protein) subunits of complex III (1:1000 and
1:1000, respectively), and COXI subunit of complex IV (1:1000)
(ref. A21344, A21343, A11143, A21346 and A6403, respectively;
Molecular Probes, Eugene, OR, USA). An antibody to porin
(1:5000, A31855, Molecular Probes, Eugene, OR, USA) or beta-
actin (1:5000, AB20272, Abcam Cambridge, MA, USA), as a
loading control for total mitochondrial mass or total protein
content, was also used. Appropriate peroxidase-coupled secondary
antibodies and chemiluminescence HRP substrate (Millipore, MA,
USA) were used for primary antibody detection. Signal quantifi-
cation and recording was performed with a ChemiDoc equipment
(Bio-Rad Laboratories, Inc., Barcelona, Spain). Protein concen-
tration was determined by the Bradford method [87]. Data were
expressed as Arbitrary Units.
Determination of MnSOD and Catalase mRNA expression
by RT-PCR
In order to extract RNA, skeletal muscles (1/10 weight/reagent
volume) were homogenized in 1 mL of Tri reagent (Sigma-
Aldrich, St. Louis, MO, USA) and RNA was isolated according to
the manufacturer’s protocol. One microgram of isolated RNA was
reverse transcribed (Eppendorf RT plus PCR kit, Hamburg,
Germany) using oligo-(dT) primer, as described by the manufac-
turer’s instructions. PCR was performed on 3-ml aliquots from
each cDNA reaction, using primer sets for detecting MnSOD (59-
GGTGGCCTTGAGCGGGGACTTG-39, 59-GGTGGGTGG-
GGAGGTAGGGAGGAT-39, sense and antisense, respectively)
and Catalase (59-ATGGCCTCCGAGATCTTTTCAATG-39,
59-GAGCGCGGTAGGGACAGTTCAC-39, sense and anti-
sense, respectively). The sizes of the amplification products were
611 bp for MnSOD and 366 bp for Catalase. Conditions for PCR
reactions were for MnSOD: 94uC for 30 sec, 58uC for 30 sec, and
72uC for 30 sec and for Catalase: 94uC for 30 sec, 57.7uC for
30 sec, and 72uC for 30 sec. PCR amplification was conducted for
29 cycles for both MnSOD and Catalase. RT-PCR products were
analyzed by agarose gel electrophoresis and digital imaging of the
ethidium bromide-stained gel, using the Alpha Innotech
FluorChem SP imaging system (Alpha Innotech, Santa Clara,
CA, USA).
Enzymatic measurement of caspase-3 and caspase-9
activities
Caspase-3 and caspase-9 activities were measured using
fluorometric protease assay kits: (Caspase-3/CPP32, Caspase-9/
Mch6, Biovision, Mountain View, CA, USA) according to
manufacturer’s instructions. Briefly, the assays are based on
detection of cleavage of the substrate DEVD-AFC (AFC: 7-amino-
4-trifluoromethyl coumarin) by caspase-3, and LEHD-AFC (AFC:
7-amino-4-trifluoromethyl Coumarin) by caspase-9. DEVD-AFC
and LEHD-AFC emit blue light (lmax = 400 nm); upon cleavage
of the respective substrate by caspase-3 or caspase-9, free AFC
emits a yellow-green fluorescence (lmax = 505 nm), which can be
quantified using a fluorescence microplate reader. Results were
expressed as raw fluorescence units per mg of cytosolic protein.
Determination of cytosolic mono- and oligonucleosomes
Apoptotic DNA fragmentation was quantified in skeletal muscle
by measuring the amount of cytosolic mono- and oligonucleo-
somes using a Cell Death detection ELISA (Roche, Germany).
Briefly, wells were coated with a monoclonal anti-histone
antibody. Nucleosomes in the sample bound to the antibody
followed by the addition of anti-DNA-peroxidase, which reacted
with the DNA associated with the histones. The amount of
peroxidase retained in the immunocomplex was determined
spectrophotometrically with ABTS (2.29-azino-di-[3-ethyl-
benzthiazoline sulfonate]) as a substrate. Results were expressed
as arbitrary OD units normalized to mg of cytosolic protein.
DNA laddering
To enable detection of nucleosomal ladders in apoptotic cells,
the DNA ladder assay was performed. Skeletal muscle was
homogenized in 1 mL DNAzol (Molecular Research Center Inc.,
Cincinnati, OH, USA). Proteinase K (Qiagen, Valencia, CA,
USA) was added to the homogenates, which, after a 3 h
incubation period, were centrifuged (10,000 6 g for 10 min at
4uC) and the supernatants were precipitated and washed with
100% and 75% ethanol, respectively. After digestion with RNase
A, DNA samples were subjected to a DNA ladder-specific ligation-
mediated PCR, following the manufacturer’s protocol (Maxim
Biotech, San Francisco, CA, USA). Briefly, isolated DNA is
subjected to an overnight ligation reaction using de-phosphory-
lated adaptors (12-mer: 59-AGTCGACACGTG-39, 27-mer: 59-
GACGTCGACGTCGTACACGTGTCGACT-39) that are ligat-
ed to the ends of DNA fragments generated during apoptosis,
using T4 DNA ligase. When the mixture is heated to 55uC, the 12-
mer is released. Next, the 59 protruding ends of the molecules are
filled by Taq polymerase. The 27-mer then serves as a primer for
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PCR in which the fragments with adaptors on both ends are
amplified. Conditions for PCR reactions were 72uC for 10 min,
94uC for 1 min, followed by 30 cycles of 94uC for 1 min and 70uC
for 2 min. PCR products were electrophoresed through 1%
agarose gels containing 0.5 mg/mL ethidium bromide at 80 V for
1 h, and were examined under UV light for the presence of
apoptosis-specific nucleosomal ladders.
Statistical Analyses
All results are expressed as means 6 SEM and the means were
compared by independent t-tests. Statistical analyses were carried
out using the Graph-Pad Prism 4.0 statistical analysis program
(San Diego, CA). Statistical significance was set to p,0.05.
Supporting Information
Table S1 Gene expression changes in gastrocnemius muscle of
13-month-old D257A mice compared to wild type mice.
Found at: doi:10.1371/journal.pone.0011468.s001 (0.03 MB
XLS)
Figure S1 No differences between WT and D257A skeletal
muscle in mitochondrial respiration at 3-mo of age. We
determined the effects of mtDNA mutations on O2 consumption
of skeletal muscle mitochondria obtained from 3-mo old (n = 8 per
group) WT and D257A mice. The respiratory control ratio (RCR),
an index of mitochondrial coupling and metabolic efficiency of
mitochondrial preparations, was calculated by dividing state 3 by
state 4 respiration values. No statistically significant differences
were detected. Error bars represent SEM.
Found at: doi:10.1371/journal.pone.0011468.s002 (0.15 MB TIF)
Figure S2 No differences in total basal and site-specific reactive
oxygen species production at 3-mo of age. Skeletal muscle
mitochondria were obtained from 3-mo old (n = 8 per group)
WT and D257A mice. We evaluated H2O2 production at
complex I in mitochondria supplemented with pyruvate/malate
(panel A) because it represents total basal mitochondrial ROS
generation. We also used inhibitors of the ETC in order to study
maximum rates of H2O2 production from complexes I and III
because they represent the main sites of ROS generation within
the mitochondria. For measuring the maximal rate of ROS
production at complex I (panel B), we added rotenone to
pyruvate/malate-supplemented mitochondria. For measurements
of the maximum rate of ROS generation at complex III (panel E),
we added antimycin A plus rotenone to succinate-supplemented
mitochondria. We also used mitochondria supplemented with
succinate alone (i.e., in the absence of any respiratory inhibitors) in
order to study complex III ROS production under near
physiological conditions (panel C). In addition, some of the assays
with succinate as substrate were performed in the presence of
rotenone (panel D), in order to avoid the backwards flow of
electrons through Complex I. Free radical leak (FRL%), an index
of mitochondrial efficiency (panel F), was calculated by dividing
the H2O2 production value by twice the state 4 respiration value
and the result was multiplied by 100 to give a final percentage
value. No statistically significant differences were detected. Error
bars represent SEM.
Found at: doi:10.1371/journal.pone.0011468.s003 (0.44 MB TIF)
Supporting File S1 Minimum information about a microarray
experiment check list. Supplemental description of gene expression
analysis of skeletal muscle from wild type and mitochondrial
mutator mice.
Found at: doi:10.1371/journal.pone.0011468.s004 (0.03 MB
DOC)
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